Clinical Trials Browser

Phase 2/3 × Colorectal Neoplasms × raltitrexed × Clear all

NCT00234429 2007-12-18

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms